Nalu Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Nalu Bio General Information

Description

Developer of a drug discovery tool designed to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS). The company's platform combines generative artificial intelligence with emerging science to design, model, and screen novel compounds, enabling the health and wellness market to address critical issues such as pain, weight management, stress, and sleep disorders with minimal side effects on a global scale.

Contact Information

Website
www.nalubio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 38 Keyes Avenue
  • Suite 200
  • San Francisco, CA 94129
  • United States
+1 (415)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 38 Keyes Avenue
  • Suite 200
  • San Francisco, CA 94129
  • United States
+1 (415)

Nalu Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nalu Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 26-Mar-2025 Completed Pre-Clinical Trials
3. Secondary Transaction - Private Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 17-Feb-2023 $12M $13.5M Completed Pre-Clinical Trials
1. Seed Round 07-Jan-2021 $1.5M $1.5M Completed Pre-Clinical Trials
To view Nalu Bio’s complete valuation and funding history, request access »

Nalu Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed 1,084,506 $0.000100 $0.94 $0.94 1x $0.94 5.76%
To view Nalu Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nalu Bio Patents

Nalu Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12679847-B1 Aryl-substituted n-alkyl indoles and their use as pharmacologically active agents Active 04-Aug-2025
US-12636296-B1 Cannabinol analogs and their use as pharmacologically active agents Active 17-Jul-2025
US-20250333392-A1 Synthesis of (-)-trans-delta-9-tetrahydrocannabivarin (delta-9 thcv) and analogs thereof Pending 08-Apr-2024
WO-2025217205-A1 Synthesis of (-)-trans-δ9-tetrahydrocannabivarin (δ9-thcv) and analogs thereof Pending 08-Apr-2024
WO-2025217205-A4 Synthesis of (-)-trans-δ9-tetrahydrocannabivarin (δ9-thcv) and analogs thereof Pending 08-Apr-2024 C07D311/80
To view Nalu Bio’s complete patent history, request access »

Nalu Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nalu Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Springboard Enterprises Accelerator/Incubator
Brown Angel Group Angel Group Minority
Intrinsic Capital Partners Growth/Expansion Minority
Portfolia Venture Capital Minority
Sacramento Angels Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Nalu Bio FAQs

  • When was Nalu Bio founded?

    Nalu Bio was founded in 2019.

  • Where is Nalu Bio headquartered?

    Nalu Bio is headquartered in San Francisco, CA.

  • What is the size of Nalu Bio?

    Nalu Bio has 14 total employees.

  • What industry is Nalu Bio in?

    Nalu Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Nalu Bio a private or public company?

    Nalu Bio is a Private company.

  • What is Nalu Bio’s current revenue?

    The current revenue for Nalu Bio is .

  • How much funding has Nalu Bio raised over time?

    Nalu Bio has raised $13.5M.

  • Who are Nalu Bio’s investors?

    Springboard Enterprises, Brown Angel Group, Intrinsic Capital Partners, Portfolia, and Sacramento Angels are 5 of 10 investors who have invested in Nalu Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process